RecruitingNCT05508932
Atrial Fibrillation in Beta-Thalassemia
Sponsor
University Hospital of Ferrara
Enrollment
350 participants
Start Date
Sep 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Transfusion-dependent Beta-thalassemia;
- Follow-Up at the Cardiology Unit of the University Hospital of Ferrara;
- Electrocardiogram performed;
- Echocardiogram performed.
Exclusion Criteria3
- Age \<18 years;
- State Of pregnancy;
- Inability to give informed consent.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05508932
Related Trials
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
NCT0680821732 locations
The CONFORM Pivotal Trial
NCT0514779283 locations
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT072275327 locations
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT0645509846 locations
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698127 locations